简明不对称合成天然蚂蚁生物碱(+)-MonomorineⅠ

运用Martin还原法高立体选择性构建顺式四氢吡咯,再经过非均相催化加氢脱保护,同时亲核闭环形成3,5-二取代吲哚里西丁双环结构。通过此方法由已知γ-内酰胺为原料5步合成天然蚂蚁生物碱(+)-MonomorineⅠ,总收率可达56%,产物与5位差向异构体的比大于20∶1。     

基于Cyclam衍生物的单核金属配合物的结构及核酸酶活性

以1,8-二甲基-1,4,8,11-四氮杂环十四烷为原料,以N,N′-二叔丁氧羰基-2-甲璜酰氧基-1,3-二氨基丙烷为烷基化试剂,合成了cyclam衍生物:1,8-二(N,N′-二叔丁氧羰基-1,3-二氨基异丙基)-4,11-二甲基-1,4,8,11-四氮杂环十四烷(L1);及其对应的系列单核金属配合物,Zn(L1)Cl2(1),Ni(L1)Cl2(2)和Cu(L1)Cl2(3);核磁结果表明,L1为C2对称结构,且cyclam环上每一个亚甲基碳上的2个氢化学不等价;利用2D[1H,15N]HSQC对比配体配位前后N-H化学位移的变化,确定配合物的结构是金属与配体cyclam环上的4个氮原子配位;利用变温核磁1H NMR和13C NMR,结合2D[1H,15N]HSQC核磁共振波谱表明,配合物1在溶液中主要以两种构型并存,并主要以trans-Ⅲ构型存在。此外,用凝胶电泳研究了配体与单核金属配合物对超螺旋p BR322质粒DNA切割活性;实验结果表明,配合物3在抗坏血酸存在的条件下具有核酸酶活性,而配体(L1),配合物1和配合物2在实验条件下,无论是氧化切割还是水解切割都显阴性。     

1,5-溴三氯甲基化产物及三取代苯乙烯的E-Z异构化（英文）

在可见光照射下,以Ir[d F(CF3)ppy]2(dtbbpy)PF6为光催化剂,α-环丙烷苯乙烯通过自由基链式反应机理进行1,5-溴三氯甲基化反应,生成三取代的苯乙烯类化合物,起始的Z/E比例为30∶70.当反应化合物进一步进行光照的时候,产物的Z/E比例最高可达99∶1.利用这一方法,成功合成了一系列的含溴三氯甲基的三取代苯乙烯化合物,产率从良好到优秀,都以Z构型为主.通过量子产率实验和荧光淬灭实验,提出了一个串联的反应历程,包含可见光引发的自由基链式反应及光催化剂催化的E-Z异构化反应.在此基础上,直接对容易制备的E构型的三取代苯乙烯类化合物进行可见光条件下的构型翻转,获得Z构型产物.     

钩吻素子的结构

中国钩吻中的主要生物碱-钩吻素-子(koumine)经用化学与与谱学方法测定其结构和和相对构型如2.钩吻素-子中醚氧的位置系用还原裂解法将2转化为双氢钩吻醇(4)而决定.碱性氮原子N(b)与乙烯基的位置关系通过将N(a)-乙酰双氢钩吻素-子(5)氧化脱羧为胺6而推定,异双氢钩吻素-子(7)经氧化为8和9,从而得到N(b)右侧的结构信息,然后通过一系列的^1H NMR去偶试验,得出钩吻素-子的碳骨架.2的相对构型系通过^1H NMR分析而判断,钩吻素-子的立体结构已由两个独立的X射线衍射工作加以肯定,其绝对构型如2所示,文中给出了详细的核磁共振数据和质谱数据,并解析了几种可能的质谱碎片化途径。     

端基含4个丁氧基苯介晶基元光致变色液晶树状物的合成、结构及液晶性研究

合成了周边含4个丁氧基偶氮苯介晶基元(M5)端基新的零代光致变色液晶树状物(D0),并用元素分析、核磁共振、基质辅助激光解吸飞行时间质谱、红外、紫外、偏光显微镜、差示扫描量热(DSC)和广角X射线衍射法(WAXD)表征.D0显示向列相,与M5相同,树状物相态由介晶基元相态所决定,D0的相行为:K138N147I145N118K.对零代(D0)、一代(D1)、二代(D2)和三代(D3)液晶树状物的清亮焓、清亮熵、熔化焓和熔化熵进行了比较.     

二取代烯基硼酸的氯化反应研究

由二取代烯基硼酸[4-substituted-1,2-oxaborol-2(5H)-ol]与N-氯代丁二酰亚胺(NCS)在甲醇中常温反应0.5 h,可以中等到良好的收率构型保持地合成得到取代的(Z)-3-氯烯丙醇,产物经1H NMR,13C NMR,FT-IR,MS和HRMS鉴定.通过该方法合成取代的(Z)-3-氯烯丙醇操作简便,反应条件温和,收率较高且反应构型能够得到保持.     

6-取代-l,4-环辛二烯的单重态氧反应——合成顺式-5,8-和反式-5,6-二取代-1,3-环辛二烯含氧衍生物的方便途径

以竹红菌甲素作敏化剂匹配高压钠灯产生单重态氧,在甲醇溶液中,氧化6-取代-1,4-环辛二烯(1),(2),并经亚硫酸钠还原,得到顺-5,8-二取代-1,3-环辛二烯和反-5,6-二取代-1,3-环辛二烯发。化合物(3)是在三氯乙烷溶液中,未经还原得到过氧化氢基取代-1,3-环辛二烯。基态分子的稳定构象决定了反应产物的立体选择性。这类反应为用光氧化方法合成顺-5,8-二取代和反-5,6-二取代-1,3-环辛二烯含氧衍生物提供了方便的途径。     

六氢吡嗪并[1,2-α]嘧啶-4,7-二酮类化合物的液相合成及其构型确证

以1-萘甲醛和2,2-二乙氧基乙胺为起始原料,经多步反应液相合成了1,6,8-三取代-六氢吡嗪并[1,2-α]嘧啶-4,7-二酮类化合物,其结构和立体构型经1H NMR和1D NOE确证.     

14-羟基菲并[9,10,3’,4’]吲哚里西啶的合成及生物活性研究

以吡咯为起始原料, 以三氟氧钒(VOF3)氧化偶联重排反应为关键步骤, 经过7步反应, 合成了结构骨架全新的14-羟基菲并[9,10,3’,4’]吲哚里西啶化合物8, 总收率为55%. 采用1H NMR, 13C NMR, IR, MS和HRMS对中间体和目标产物进行了表征. 初步的抗烟草花叶病毒生物活性测试结果表明, 目标化合物8对烟草花叶病毒无明显抑制作用, 但具有较好的抗肿瘤活性, 中间体9-氧代-14-羟基-14a-甲氧基菲并[9,10,3’,4’]吲哚里西啶化合物7却表现出了很好的抗烟草花叶病毒活性.     

可见光驱动的偶氮苯分子开关的理论设计与计算模拟

可见光驱动的偶氮苯等光致异构材料在生物探针和传感体系、光敏电池以及储能材料等领域有重要的应用前景.采用密度泛函理论(DFT)以及反应性分子动力学方法,研究了卤素原子(F,Cl,Br,I)四邻位取代的4,4′-乙酰胺偶氮苯衍生物分子的几何结构与光学性能之间的关系.DFT计算表明,卤素原子F,Cl,Br,I的邻位四取代不同程度地使其反式异构体的偶氮苯分子平面发生扭曲,导致在可见光范围内均出现了明显的吸收峰.另外,应用反应性分子动力学模拟了卤素(F,Cl,Br,I)-4,4′-乙酰胺偶氮苯分子的顺反可逆异构过程,其反式到顺式的构型转换率在46%~86%之间,与实验现象定性相符.     

The enantioselective synthesis of poison-frog alkaloids (−)-203A, (−)-209B, (−)-231C, (−)-233D, and (−)-235B″

The enantioselective synthesis of indolizidines (−)-203A, (−)-209B, (−)-231C, (−)-233D, and (−)-235B″ has been achieved and the absolute stereochemistry of both indolizidines 203A and 233D was established as 5S,8R,9S. The relative stereochemistry of natural 231C was established by the present asymmetric synthesis.     

Organometallic enantiomeric scaffolding: a strategy for the enantiocontrolled construction of regio- and stereodivergent trisubstituted piperidines from a common precursor

Reported herein is a general and efficient method to construct 2,3,6-trisubstituted piperidines in a substituent-independent fashion. From the high enantiopurity organometallic scaffold (-)-Tp(CO)(2)[(η-2,3,4)-(1S,2S)-1-benzyloxycarbonyl-5-oxo-5,6-dihydro-2H-pyridin-2-yl)molybdenum (Tp = hydridotrispyrazolylborato), a variety of TpMo(CO)(2)-based 2,3,6-trifunctionalized complexes of the (η-3,4,5-dihydropyridinyl) ligand were easily obtained in 5 steps through a sequence of highly regio- and stereospecific metal-influenced transformations (15 examples). From the 2,3,6-trifunctionalized molybdenum complexes, either 2,6-cis-3-trans or 2,3,6-cis systems were selectively obtained through the choice of an appropriate stereodivergent demetalation protocol. The potential of this strategy in synthetic chemistry was demonstrated by the short total synthesis of four natural and one non-natural alkaloids: indolizidines (±)-209I and (±)-8-epi-219F in the racemic series, and enantiocontrolled syntheses of (-)-indolizidine 251N, (-)-quinolizidine 251AA, and (-)-dehydroindolizidine 233E.     

A stereospecific synthesis of (+/-)-5,8-disubstituted indolizidines and (+/-)-1,4-disubstituted quinolizidines found in poison frog skins

An efficient, high-yield stereospecific route to three (+/-)-5, 8-disubstituted indolizidines, (209B (I), 209I (II), 223J (III)) and two (+/-)-1,4-disubstituted quinolizidines (207I (IV), 233A (V)), racemates of alkaloids found in the skins of neotropical and Madagascan poison frogs is reported. The structures of the natural alkaloids were thereby established by chiral GC comparison with the exception of indolizidine 209B (I) for which a natural 209B could no longer be detected.     

Enantioselective syntheses of poison-frog alkaloids: 219F and 221I and an epimer of 193E

Enantioselective syntheses of indolizidines (−)-219F and (−)-221I have been achieved and the relative stereochemistries of natural 219F and 221I were determined by the present synthesis. A levorotatory indolizidine, corresponding to one proposed structure for 193E, was also synthesized, but was found to differ from 193E. It seems likely that natural 193E is the 8-epimer of the synthesized indolizidine.     

Indolizidine and quinolizidine alkaloids

This review covers the isolation, structure determination, synthesis, chemical transformations and biological activity of indolizidine and quinolizidine alkaloids. Included in the review are the hydroxylated indolizidines lentiginosine, swainsonine, castanospermine and their analogues; alkaloids from animal sources, including arthropods and amphibians; alkaloids from the genera Polygonatum, Prosopis and Poranthera; phenanthroindolizidine and phenanthroquinolizidine alkaloids; Nuphar alkaloids; lupine alkaloids; and alkaloids from marine sources. 130 references are cited.     

Indolizidine and quinolizidine alkaloids

This review covers the isolation, structure determination, synthesis, chemical transformations and biological activity of indolizidine and quinolizidine alkaloids. Included in the review are the hydroxylated indolizidines lentiginosine, swainsonine, castanospermine and their analogues; alkaloids from animal sources, including ants, amphibians and beetles; indolizidine alkaloids from the genera Polygonatum, Prosopis and Elaeocarpus; indolizidine and phenanthroindolizidine alkaloids; alkylquinolizidine alkaloids, including myrtine, epimyrtine, plumerinine and Lycopodium metabolites; Lythraceae and Nuphar alkaloids; lupine alkaloids; and alkaloids from marine sources. 150 references are cited.     

Indolizidine and quinolizidine alkaloids

This review covers the isolation, structure determination, synthesis and biological activity of indolizidine and quinolizidine alkaloids from microbial, plant and animal sources. Included in the review are slaframine; hydroxylated indolizidines and their analogues; alkaloids from ants and amphibians; metabolites of the genera Prosopis, Streptomyces and Nuphar and the Lythraceae; phenanthroindolizidines and related alkaloids; lupin alkaloids; and alkaloids from sponges. tunicates and coccinellid beetles. The literature from July 2000 to June 2001 is reviewed, and 172 references are cited.     

Indolizidine and quinolizidine alkaloids

This review covers the isolation, structure determination, synthesis, chemical transformations and biological activity of indolizidine and quinolizidine alkaloids from microbial, plant and animal sources. Included in the review are slaframine; the hydroxylated indolizidines lentiginosine, swainsonine, castanospermine and their analogues; alkaloids from amphibians and marine sources; plumerinine; ipalbidine, phenanthroindolizidines and related alkaloids; lasubine-II: and lupin alkaloids. The literature from July 2001 to June 2002 is reviewed, and 142 references are cited.     

Indolizidine and quinolizidine alkaloids

This review covers the isolation, structure determination, synthesis, chemical transformations and biological activity of indolizidine and quinolizidine alkaloids from microbial, plant and animal sources. Included in the review are the hydroxylated indolizidines lentiginosine, swainsonine, castanospermine and their analogues; alkaloids from animal sources, including ants, amphibians and beetles; ipalbidine, phenanthroindolizidines and related alkaloids; Lycopodium alkaloids; lupine alkaloids; and alkaloids from bacterial and marine sources. The literature from July 2002 to June 2003 is reviewed, and 174 references are cited.     

One-pot tandem route to fused indolizidines and quinolizidines: Application in the synthesis of alkaloids and bioactive compounds

Fused indolizidines and quinolizidines are important skeletons in a variety of natural products and pharmacologically important compounds. A one-pot tandem route from amide to fused indolizidines and quinolizidines is disclosed. This method is conducted in mild conditions and shows well tolerance of functional groups. It is also easy to be scaled up to gram scale and can be applied smoothly to the total synthesis of alkaloids such as (±)-crispine A, (±)-xylopinine, (±)-desbromoarborescidine A, (±)-harmicine and other bioactive substances.